2015
DOI: 10.1016/j.chemosphere.2015.06.083
|View full text |Cite
|
Sign up to set email alerts
|

LC–MS screening techniques for wastewater analysis and analytical data handling strategies: Sartans and their transformation products as an example

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
50
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 65 publications
(52 citation statements)
references
References 32 publications
2
50
0
Order By: Relevance
“…Although the decrease of valsartan came along with an increase of valsartan acid, formation of valsartan acid cannot be solely attributed to transformation of valsartan. It is suggested that degradation of other compounds such as irbesartan, which was not analyzed, might have contributed to valsartan acid formation [55]. In the second infiltration step, valsartan acid is efficiently attenuated in all systems with aeration (SMART air: 95%, SMART O2/O3: >99%), whereas it remained constant in the anoxic reference system (Figure 7b).…”
Section: Formation and Fate Of The Transformation Product Valsartan Acidmentioning
confidence: 94%
See 1 more Smart Citation
“…Although the decrease of valsartan came along with an increase of valsartan acid, formation of valsartan acid cannot be solely attributed to transformation of valsartan. It is suggested that degradation of other compounds such as irbesartan, which was not analyzed, might have contributed to valsartan acid formation [55]. In the second infiltration step, valsartan acid is efficiently attenuated in all systems with aeration (SMART air: 95%, SMART O2/O3: >99%), whereas it remained constant in the anoxic reference system (Figure 7b).…”
Section: Formation and Fate Of The Transformation Product Valsartan Acidmentioning
confidence: 94%
“…Valsartan acid is a known transformation product from biodegradation of different sartanes such as valsartan, irbesartan, candesartan, and olmesartan [55]. In Figure 7a, changes of molar concentrations of valsartan, olmesartan, candesartan, and valsartan acid in the first filtration step are illustrated.…”
Section: Formation and Fate Of The Transformation Product Valsartan Acidmentioning
confidence: 99%
“…1) falls into the "hidden target" area of non-target screening, hypothesized by Letzel et al (2015), wherein non-target techniques (i.e. peak picking) are originally applied, but a database (i.e.…”
Section: General Workflowmentioning
confidence: 99%
“…Consequently, subsequent steps must then be made to reduce the number of peaks to a more manageable number, including molecular formula derivation, isotopic pattern, mass defect analysis and retention time prediction (Gago-Ferrero et al, 2015;Helbling et al, 2010;Kind and Fiehn, 2007). Further confidence in the "potential positives" remaining can be gained through the use of fragmentation in a subsequent MS/MS injection and comparison with in silico fragmentation and/or mass spectral libraries Gerlich and Neumann, 2013;Herrera-Lopez et al, 2014;Hug et al, 2014;Little et al, 2012), with the latter referred to as "hidden targets" (Letzel et al, 2015). In these situations, it is of prime importance and for ease of the analyst to have software capable of fulfilling most (if not all) of these steps automatically.…”
Section: Introductionmentioning
confidence: 99%
“…[16] This allows for narrowing possible candidates to a certain molecular formula. [18] A crucial step in any screening is peak selection, which can be achieved using a software algorithm. [13,17] This identification approach is limited to identification of compounds present on the structure candidate list, and therefore referred to as 'hidden targets' or known unknowns.…”
Section: Introductionmentioning
confidence: 99%